Selected Publications
Chakraborti Y, Mumford SL, Yeung EH, Grantz KL, Mendola P, Mills JL, Caniglia EC, Brensinger CM, Zhang C, Schisterman EF, Hinkle SN.: Weight Change Between Pregnancies and Mortality Over 50 Years of Follow-Up. Obesity (Silver Spring) May 2026.
DiTosto JD, Lewey J, Zee J, Dokras A, Busse KR, Alur-Gupta S, Hinkle SN, Schisterman EF, Mumford SL, Caniglia EC.: Emulating a Target Trial of Surgical Removal of Uterine Fibroids on Atherosclerotic Cardiovascular Disease. Fertil Steril May 2026.
Sealy NRZ, Mumford SL, Caniglia EC, DiTosto JD, Johnstone EB, Hotaling J, Van Voorhis BJ, Ryan G, Mendola P, Schisterman EF, Hinkle SN.: Supplement use among couples seeking fertility treatment and associations with live birth and pregnancy loss. Fertil Steril Apr 2026.
Moeng L, Kebaabetswe P, Diseko M, Zash R, Mayondi G, Mabuta J, Mmalane M, Makhema J, Lockman S, Lowenthal E, Shapiro R, Caniglia EC.: Healthcare Providers' Perceptions and Experiences of Prenatal Iron and Folic Acid Supplementation-A Qualitative Study in Botswana. Curr Dev Nutr 10: 107660, Feb 2026.
Feelemyer J, Ban FK, Braithwaite RS, Bhattacharya D, Caniglia EC, Justice AC, Kim JK, Lo Re V, Scheidell J, Rentsch CT, Khan M: Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response. Journal of Viral Hepatitis 33(1): e70116, January 2026.
Latour CD, Caniglia EC.: Interpreting Impacts of Population-Level Interventions in the Presence of Exposure Misclassification. Paediatr Perinat Epidemiol 2026.
DiTosto JD, Sealy NRZ, Hinkle SN, Schisterman EF, Dokras A, Mumford SL, Caniglia EC.: The Invisible Burden: Examining the Impact of Exposure Misclassification in Epidemiologic Analyses of Uterine Fibroids. Paediatr Perinat Epidemiol 2026.
Caniglia EC, Zash R, Diseko M, Mabuta J, Mmalane M, Lockman S, Mayondi G, Masheto G, Mayhem J, Shapiro R: Target trials of pre-conception switch from Nevirapine- or Efavirenz-based ART to Dolutegravir-based ART on adverse birth and maternal outcomes. AIDS Aug 2025 Notes: doi: 10.1097/QAD.0000000000004321; Epub ahead of print.
DiTosto JD, Leve J, Zee J, Dokras A, Busse KR, Alur-Gupta S, Hinkle S, Schisterman EF, Mumford SL, Caniglia EC: Association Between Uterine Fibroids and Risk of Atherosclerotic Cardiovascular Disease. Journal of the American Heart Association 15: e044014, December 2025.
Caniglia EC, Zash R, Diseko M, Mabuta J, Mmalane M, Lockman S, Mayondi G, Masheto G, Makhema J, Shapiro R.: Target trials of preconception switch from nevirapine or efavirenz-based antiretroviral therapy to dolutegravir-based antiretroviral therapy on adverse birth and maternal outcomes. AIDS 39: 2103-2113, Nov 2025.
back to top
Last updated: 05/21/2026
The Trustees of the University of Pennsylvania